Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Integration of ER protein quality-control mechanisms defines β cell function and ER architecture
Neha Shrestha, … , Peter Arvan, Ling Qi
Neha Shrestha, … , Peter Arvan, Ling Qi
Published November 8, 2022
Citation Information: J Clin Invest. 2023;133(1):e163584. https://doi.org/10.1172/JCI163584.
View: Text | PDF
Research Article Cell biology Metabolism

Integration of ER protein quality-control mechanisms defines β cell function and ER architecture

  • Text
  • PDF
Abstract

Three principal ER quality-control mechanisms, namely, the unfolded protein response, ER-associated degradation (ERAD), and ER-phagy are each important for the maintenance of ER homeostasis, yet how they are integrated to regulate ER homeostasis and organellar architecture in vivo is largely unclear. Here we report intricate crosstalk among the 3 pathways, centered around the SEL1L-HRD1 protein complex of ERAD, in the regulation of organellar organization in β cells. SEL1L-HRD1 ERAD deficiency in β cells triggers activation of autophagy, at least in part, via IRE1α (an endogenous ERAD substrate). In the absence of functional SEL1L-HRD1 ERAD, proinsulin is retained in the ER as high molecular weight conformers, which are subsequently cleared via ER-phagy. A combined loss of both SEL1L and autophagy in β cells leads to diabetes in mice shortly after weaning, with premature death by approximately 11 weeks of age, associated with marked ER retention of proinsulin and β cell loss. Using focused ion beam scanning electron microscopy powered by deep-learning automated image segmentation and 3D reconstruction, our data demonstrate a profound organellar restructuring with a massive expansion of ER volume and network in β cells lacking both SEL1L and autophagy. These data reveal at an unprecedented detail the intimate crosstalk among the 3 ER quality-control mechanisms in the dynamic regulation of organellar architecture and β cell function.

Authors

Neha Shrestha, Mauricio Torres, Jason Zhang, You Lu, Leena Haataja, Rachel B. Reinert, Jeffrey Knupp, Yu-Jie Chen, Allen H. Hunter, Gunes Parlakgul, Ana Paula Arruda, Billy Tsai, Peter Arvan, Ling Qi

×

Figure 1

Basal autophagy is activated in ERAD-deficient β cells in part via IRE1α.

Options: View larger image (or click on image) Download as PowerPoint
Basal autophagy is activated in ERAD-deficient β cells in part via IRE1α...
(A) UMAP plots of islets from WT (left) and Sel1LIns1 male mice (right). Scale bars represent autophagic activity inferred from 20 reported autophagy-induced genes. (B) Representative TEM images of WT and Sel1LIns1 islets, showing elevated autophagosomes (arrows) in basal state (n = 2 mice). ER, endoplasmic reticulum; M, mitochondria; SG, secretory granules; G, Golgi. Scale bars: 800 nm (top) and 200 nm (bottom). (C) Western blot showing expression of autophagy and UPR genes (n = 4–6 per group). (D) Western blot showing expression of LC3 in the presence of chloroquine (CHLQ) for 2 hours, with quantitation of net LC3 flux shown below (n = 4). (E) Western blot analyses, under nonreducing (without dithiothreitol [–]) and reducing (+) conditions, of proinsulin in islets with or without treatment with chloroquine (2 independent repeats). (F) Western blot showing basal autophagy and autophagic flux in islets from indicated genotypes (quantitation is shown below, n = 3). (G) Western blotting analyses, under nonreducing and reducing conditions, of proinsulin in islets of indicated genotypes (n = 3), with quantification shown on the right. Values are shown as mean ± SEM. *P < 0.05; **P < 0.005; ***P < 0.001; ****P < 0.0001 by unpaired, 2-tailed Student’s t test (C and D) or 1-way ANOVA with Tukey’s post hoc test (F and G).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts